{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:34:58Z","timestamp":1792715698695,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:00:00Z","timestamp":1704844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:00:00Z","timestamp":1704844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["No. 963845"],"award-info":[{"award-number":["No. 963845"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["No. 964537"],"award-info":[{"award-number":["No. 964537"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Adverse outcome pathways (AOPs) were introduced in modern toxicology to provide evidence-based representations of the events and processes involved in the progression of toxicological effects across varying levels of the biological organisation to better facilitate the safety assessment of chemicals. AOPs offer an opportunity to address knowledge gaps and help to\u00a0identify novel therapeutic targets. They also aid in the selection and development of existing and new in vitro and in silico test methods for hazard identification and risk assessment of chemical compounds. However, many toxicological processes are too intricate to be captured in a single, linear AOP. As a result, AOP networks have been developed to aid in the comprehension and placement of associated events underlying the emergence of related forms of toxicity\u2014where complex exposure scenarios and interactions may influence the ultimate adverse outcome. This study utilised established criteria to develop an AOP network that connects thirteen individual AOPs associated with nephrotoxicity (as sourced from the AOP-Wiki) to identify several key events (KEs) linked to various adverse outcomes, including kidney failure and chronic kidney disease. Analysis of the modelled AOP network and its topological features determined mitochondrial dysfunction, oxidative stress, and tubular necrosis to be the most connected and central KEs. These KEs can provide a logical foundation for guiding the selection and creation of in vitro assays and in silico tools to substitute for animal-based in vivo experiments in the prediction and assessment of chemical-induced nephrotoxicity in human health.<\/jats:p>","DOI":"10.1007\/s00204-023-03637-7","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T10:02:45Z","timestamp":1704880965000},"page":"929-942","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Development of an adverse outcome pathway network for nephrotoxicity"],"prefix":"10.1007","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2037-2824","authenticated-orcid":false,"given":"D. A.","family":"Barnes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0319-1407","authenticated-orcid":false,"given":"J. W.","family":"Firman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6532-2532","authenticated-orcid":false,"given":"S. J.","family":"Belfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6207-4158","authenticated-orcid":false,"given":"M. T. D.","family":"Cronin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5115-8893","authenticated-orcid":false,"given":"M.","family":"Vinken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0544-8096","authenticated-orcid":false,"given":"M. J.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1560-1074","authenticated-orcid":false,"given":"R.","family":"Masereeuw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,10]]},"reference":[{"issue":"24","key":"3637_CR1","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.1093\/bioinformatics\/btz570","volume":"35","author":"A Aguayo-Orozco","year":"2019","unstructured":"Aguayo-Orozco A, Audouze K, Siggaard T, Barouki R, Brunak S, Taboureau O (2019) sAOP: linking chemical stressors to adverse outcomes pathway networks. Bioinformatics 35(24):5391\u20135392","journal-title":"Bioinformatics"},{"key":"3637_CR2","doi-asserted-by":"crossref","unstructured":"Aguilar Diaz De Leon J, Borges CR (2020) Evaluation of oxidative stress in biological samples using the thiobarbituric acid reactive substances assay. J Vis Exp (159)","DOI":"10.3791\/61122-v"},{"issue":"3","key":"3637_CR3","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/etc.34","volume":"29","author":"GT Ankley","year":"2010","unstructured":"Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, Johnson RD, Mount DR, Nichols JW, Russom CL, Schmieder PK, Serrrano JA, Tietge JE, Villeneuve DL (2010) Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem 29(3):730\u2013741","journal-title":"Environ Toxicol Chem"},{"key":"3637_CR4","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2021.152856","volume":"459","author":"E Arnesdotter","year":"2021","unstructured":"Arnesdotter E, Spinu N, Firman J, Ebbrell D, Cronin MTD, Vanhaecke T, Vinken M (2021) Derivation, characterisation and analysis of an adverse outcome pathway network for human hepatotoxicity. Toxicology 459:152856","journal-title":"Toxicology"},{"key":"3637_CR5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.yrtph.2017.02.017","volume":"86","author":"RA Becker","year":"2017","unstructured":"Becker RA, Dellarco V, Seed J, Kronenberg JM, Meek B, Foreman J, Palermo C, Kirman C, Linkov I, Schoeny R, Dourson M, Pottenger LH, Manibusan MK (2017) Quantitative weight of evidence to assess confidence in potential modes of action. Regul Toxicol Pharmacol 86:205\u2013220","journal-title":"Regul Toxicol Pharmacol"},{"issue":"5","key":"3637_CR6","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.3390\/ijms22052366","volume":"22","author":"P Chazelas","year":"2021","unstructured":"Chazelas P, Steichen C, Favreau F, Trouillas P, Hannaert P, Thuillier R, Giraud S, Hauet T, Guillard J (2021) Oxidative stress evaluation in ischemia reperfusion models: characteristics, limits and perspectives. Int J Mol Sci 22(5):2366","journal-title":"Int J Mol Sci"},{"key":"3637_CR7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/B978-0-12-416618-9.00012-1","volume":"542","author":"J Chen","year":"2014","unstructured":"Chen J, Mathews CE (2014) Use of chemical probes to detect mitochondrial ROS by flow cytometry and spectrofluorometry. Methods Enzymol 542:223\u2013241","journal-title":"Methods Enzymol"},{"key":"3637_CR8","first-page":"4","volume":"3","author":"MTD Cronin","year":"2017","unstructured":"Cronin MTD, Richarz AN (2017) Relationship between adverse outcome pathways and chemistry-based in silico models to predict toxicity. Mary Ann 3:4","journal-title":"Mary Ann"},{"issue":"5","key":"3637_CR9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/10408444.2022.2082269","volume":"52","author":"KO Goyak","year":"2022","unstructured":"Goyak KO, Sarang SS, Franzen A, Borghoff SJ, Ryman-Rasmussen JP (2022) Adverse outcome pathway (AOP): alpha2u-globulin nephropathy and kidney tumors in male rats. Crit Rev Toxicol 52(5):345\u2013357","journal-title":"Crit Rev Toxicol"},{"key":"3637_CR10","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.chemosphere.2014.09.068","volume":"120","author":"KJ Groh","year":"2015","unstructured":"Groh KJ, Carvalho RN, Chipman JK, Denslow ND, Halder M, Murphy CA, Roelofs D, Rolaki A, Schirmer K, Watanabe KH (2015) Development and application of the adverse outcome pathway framework for understanding and predicting chronic toxicity: I. Challenges and research needs in ecotoxicology. Chemosphere 120:764\u2013777","journal-title":"Chemosphere"},{"issue":"8","key":"3637_CR11","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.3390\/ijms23084397","volume":"23","author":"Y Gueguen","year":"2022","unstructured":"Gueguen Y, Frerejacques M (2022) Review of knowledge of Uranium-induced kidney toxicity for the development of an adverse outcome pathway to renal impairment. Int J Mol Sci 23(8):4397","journal-title":"Int J Mol Sci"},{"key":"3637_CR12","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2022.864441","volume":"4","author":"S Jarzina","year":"2022","unstructured":"Jarzina S, Di Fiore S, Ellinger B, Reiser P, Frank S, Glaser M, Wu J, Taverne FJ, Kramer NI, Mally A (2022) Application of the adverse outcome pathway concept to in vitro nephrotoxicity assessment: kidney injury due to receptor-mediated endocytosis and lysosomal overload as a case study. Front Toxicol 4:864441","journal-title":"Front Toxicol"},{"key":"3637_CR13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-1-4939-7477-1_9","volume":"1709","author":"AE Kabakov","year":"2018","unstructured":"Kabakov AE, Gabai VL (2018) Cell death and survival assays. Methods Mol Biol 1709:107\u2013127","journal-title":"Methods Mol Biol"},{"issue":"3","key":"3637_CR14","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4062\/biomolther.2012.20.3.268","volume":"20","author":"SY Kim","year":"2012","unstructured":"Kim SY, Moon A (2012) Drug-induced nephrotoxicity and its biomarkers. Biomol Ther (seoul) 20(3):268\u2013272","journal-title":"Biomol Ther (seoul)"},{"key":"3637_CR15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.yrtph.2016.01.007","volume":"76","author":"NC Kleinstreuer","year":"2016","unstructured":"Kleinstreuer NC, Sullivan K, Allen D, Edwards S, Mendrick DL, Embry M, Matheson J, Rowlands JC, Munn S, Maull E, Casey W (2016) Adverse outcome pathways: from research to regulation scientific workshop report. Regul Toxicol Pharmacol 76:39\u201350","journal-title":"Regul Toxicol Pharmacol"},{"key":"3637_CR16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.reprotox.2015.04.003","volume":"56","author":"D Knapen","year":"2015","unstructured":"Knapen D, Vergauwen L, Villeneuve DL, Ankley GT (2015) The potential of AOP networks for reproductive and developmental toxicity assay development. Reprod Toxicol 56:52\u201355","journal-title":"Reprod Toxicol"},{"issue":"6","key":"3637_CR17","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/etc.4125","volume":"37","author":"D Knapen","year":"2018","unstructured":"Knapen D, Angrish MM, Fortin MC, Katsiadaki I, Leonard M, Margiotta-Casaluci L, Munn S, O\u2019Brien JM, Pollesch N, Smith LC, Zhang X, Villeneuve DL (2018) Adverse outcome pathway networks I: development and applications. Environ Toxicol Chem 37(6):1723\u20131733","journal-title":"Environ Toxicol Chem"},{"issue":"11","key":"3637_CR18","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.3390\/ijms22116109","volume":"22","author":"E Kwiatkowska","year":"2021","unstructured":"Kwiatkowska E, Domanski L, Dziedziejko V, Kajdy A, Stefanska K, Kwiatkowski S (2021) The mechanism of drug nephrotoxicity and the methods for preventing kidney damage. Int J Mol Sci 22(11):6109","journal-title":"Int J Mol Sci"},{"key":"3637_CR19","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/420601","volume":"2013","author":"N Lall","year":"2013","unstructured":"Lall N, Henley-Smith CJ, De Canha MN, Oosthuizen CB, Berrington D (2013) Viability reagent, PrestoBlue, in comparison with other available reagents, utilized in cytotoxicity and antimicrobial assays. Int J Microbiol 2013:420601","journal-title":"Int J Microbiol"},{"issue":"6","key":"3637_CR20","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/1073858410385469","volume":"17","author":"NZ Lax","year":"2011","unstructured":"Lax NZ, Turnbull DM, Reeve AK (2011) Mitochondrial mutations: newly discovered players in neuronal degeneration. Neuroscientist 17(6):645\u2013658","journal-title":"Neuroscientist"},{"key":"3637_CR21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","volume":"53","author":"Q Ma","year":"2013","unstructured":"Ma Q (2013) Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol 53:401\u2013426","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"3","key":"3637_CR22","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00204-022-03435-7","volume":"97","author":"P Marx-Stoelting","year":"2023","unstructured":"Marx-Stoelting P, Riviere G, Luijten M, Aiello-Holden K, Bandow N, Baken K, Canas A, Castano A, Denys S, Fillol C, Herzler M, Iavicoli I, Karakitsios S, Klanova J, Kolossa-Gehring M, Koutsodimou A, Vicente JL, Lynch I, Namorado S et al (2023) A walk in the PARC: developing and implementing 21st century chemical risk assessment in Europe. Arch Toxicol 97(3):893\u2013908","journal-title":"Arch Toxicol"},{"key":"3637_CR23","volume-title":"Guidance document on developing and assessing adverse outcome pathways","author":"OECD","year":"2017","unstructured":"OECD (2017) Guidance document on developing and assessing adverse outcome pathways. OECD publishing, Paris"},{"key":"3637_CR24","volume-title":"Adverse outcome pathways, molecular screening and toxicogenomics","author":"OECD","year":"2018","unstructured":"OECD (2018a) Adverse outcome pathways, molecular screening and toxicogenomics. OECD publishing, Paris"},{"key":"3637_CR25","doi-asserted-by":"crossref","DOI":"10.1787\/ceca15a9-en","volume-title":"Considerations for assessing the risks of combined exposure to multiple chemicals","author":"OECD","year":"2018","unstructured":"OECD (2018b) Considerations for assessing the risks of combined exposure to multiple chemicals. OECD publishing, Paris"},{"key":"3637_CR26","volume-title":"Users\u2019 handbook supplement to the guidance document for developing and assessing adverse outcome pathways","author":"OECD","year":"2018","unstructured":"OECD (2018c) Users\u2019 handbook supplement to the guidance document for developing and assessing adverse outcome pathways. OECD publishing, Paris"},{"issue":"5","key":"3637_CR27","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00467-018-3921-7","volume":"34","author":"P Outtandy","year":"2019","unstructured":"Outtandy P, Russell C, Kleta R, Bockenhauer D (2019) Zebrafish as a model for kidney function and disease. Pediatr Nephrol 34(5):751\u2013762","journal-title":"Pediatr Nephrol"},{"key":"3637_CR28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/978-1-60761-756-3_18","volume":"648","author":"JB Owen","year":"2010","unstructured":"Owen JB, Butterfield DA (2010) Measurement of oxidized\/reduced glutathione ratio. Methods Mol Biol 648:269\u2013277","journal-title":"Methods Mol Biol"},{"issue":"9","key":"3637_CR29","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/etc.4505","volume":"38","author":"EJ Perkins","year":"2019","unstructured":"Perkins EJ, Ashauer R, Burgoon L, Conolly R, Landesmann B, Mackay C, Murphy CA, Pollesch N, Wheeler JR, Zupanic A, Scholz S (2019) Building and applying quantitative adverse outcome pathway models for chemical hazard and risk assessment. Environ Toxicol Chem 38(9):1850\u20131865","journal-title":"Environ Toxicol Chem"},{"issue":"12","key":"3637_CR30","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1080\/17425255.2018.1539076","volume":"14","author":"J Pletz","year":"2018","unstructured":"Pletz J, Enoch SJ, Jais DM, Mellor CL, Pawar G, Firman JW, Madden JC, Webb SD, Tagliati CA, Cronin MTD (2018) A critical review of adverse effects to the kidney: mechanisms, data sources, and in silico tools to assist prediction. Expert Opin Drug Metab Toxicol 14(12):1225\u20131253","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"10","key":"3637_CR31","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.2850","volume":"8","author":"B Plitzko","year":"2018","unstructured":"Plitzko B, Loesgen S (2018) Measurement of Oxygen Consumption Rate (OCR) and Extracellular Acidification Rate (ECAR) in Culture Cells for Assessment of the Energy Metabolism. Bio Protoc 8(10):e2850","journal-title":"Bio Protoc"},{"issue":"2","key":"3637_CR32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/toxsci\/kfz006","volume":"168","author":"NL Pollesch","year":"2019","unstructured":"Pollesch NL, Villeneuve DL, O\u2019Brien JM (2019) Extracting and benchmarking emerging adverse outcome pathway knowledge. Toxicol Sci 168(2):349\u2013364","journal-title":"Toxicol Sci"},{"key":"3637_CR33","doi-asserted-by":"crossref","first-page":"484","DOI":"10.12688\/f1000research.6769.1","volume":"4","author":"G Scardoni","year":"2015","unstructured":"Scardoni G, Tosadori G, Pratap S, Spoto F, Laudanna C (2015) Finding the shortest path with PesCa: a tool for network reconstruction. F1000Res 4:484","journal-title":"F1000Res"},{"issue":"4","key":"3637_CR34","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s00204-018-2183-2","volume":"92","author":"F Sewell","year":"2018","unstructured":"Sewell F, Gellatly N, Beaumont M, Burden N, Currie R, de Haan L, Hutchinson TH, Jacobs M, Mahony C, Malcomber I, Mehta J, Whale G, Kimber I (2018) The future trajectory of adverse outcome pathways: a commentary. Arch Toxicol 92(4):1657\u20131661","journal-title":"Arch Toxicol"},{"issue":"11","key":"3637_CR35","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498\u20132504","journal-title":"Genome Res"},{"key":"3637_CR36","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.3128","author":"F Sivandzade","year":"2019","unstructured":"Sivandzade F, Bhalerao A, Cucullo L (2019) Analysis of the Mitochondrial Membrane Potential Using the Cationic JC-1 Dye as a Sensitive Fluorescent Probe. Bio Protoc. https:\/\/doi.org\/10.21769\/BioProtoc.3128","journal-title":"Bio Protoc"},{"issue":"10","key":"3637_CR37","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1007\/s00204-019-02551-1","volume":"93","author":"N Spinu","year":"2019","unstructured":"Spinu N, Bal-Price A, Cronin MTD, Enoch SJ, Madden JC, Worth AP (2019) Development and analysis of an adverse outcome pathway network for human neurotoxicity. Arch Toxicol 93(10):2759\u20132772","journal-title":"Arch Toxicol"},{"issue":"2","key":"3637_CR38","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/toxsci\/kfu199","volume":"142","author":"DL Villeneuve","year":"2014","unstructured":"Villeneuve DL, Crump D, Garcia-Reyero N, Hecker M, Hutchinson TH, LaLone CA, Landesmann B, Lettieri T, Munn S, Nepelska M, Ottinger MA, Vergauwen L, Whelan M (2014) Adverse outcome pathway (AOP) development I: strategies and principles. Toxicol Sci 142(2):312\u2013320","journal-title":"Toxicol Sci"},{"issue":"6","key":"3637_CR39","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1002\/etc.4124","volume":"37","author":"DL Villeneuve","year":"2018","unstructured":"Villeneuve DL, Angrish MM, Fortin MC, Katsiadaki I, Leonard M, Margiotta-Casaluci L, Munn S, O\u2019Brien JM, Pollesch NL, Smith LC, Zhang X, Knapen D (2018) Adverse outcome pathway networks II: Network analytics. Environ Toxicol Chem 37(6):1734\u20131748","journal-title":"Environ Toxicol Chem"},{"key":"3637_CR40","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tox.2013.08.011","volume":"312","author":"M Vinken","year":"2013","unstructured":"Vinken M (2013) The adverse outcome pathway concept: a pragmatic tool in toxicology. Toxicology 312:158\u2013165","journal-title":"Toxicology"},{"issue":"11","key":"3637_CR41","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1007\/s00204-017-2020-z","volume":"91","author":"M Vinken","year":"2017","unstructured":"Vinken M, Knapen D, Vergauwen L, Hengstler JG, Angrish M, Whelan M (2017) Adverse outcome pathways: a concise introduction for toxicologists. Arch Toxicol 91(11):3697\u20133707","journal-title":"Arch Toxicol"},{"key":"3637_CR42","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2021.152846","volume":"458","author":"M Vinken","year":"2021","unstructured":"Vinken M, Benfenati E, Busquet F, Castell J, Clevert DA, de Kok TM, Dirven H, Fritsche E, Geris L, Gozalbes R, Hartung T, Jennen D, Jover R, Kandarova H, Kramer N, Krul C, Luechtefeld T, Masereeuw R, Roggen E et al (2021) Safer chemicals using less animals: kick-off of the European ONTOX project. Toxicology 458:152846","journal-title":"Toxicology"},{"key":"3637_CR43","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ab.2017.07.009","volume":"552","author":"LD Zorova","year":"2018","unstructured":"Zorova LD, Popkov VA, Plotnikov EY, Silachev DN, Pevzner IB, Jankauskas SS, Babenko VA, Zorov SD, Balakireva AV, Juhaszova M, Sollott SJ, Zorov DB (2018) Mitochondrial membrane potential. Anal Biochem 552:50\u201359","journal-title":"Anal Biochem"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-023-03637-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-023-03637-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-023-03637-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T16:12:56Z","timestamp":1708013576000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-023-03637-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,10]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["3637"],"URL":"https:\/\/doi.org\/10.1007\/s00204-023-03637-7","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,10]]},"assertion":[{"value":"7 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}